Stephenson Brian C: insider trades.
Stephenson Brian C reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 6 open-market purchases ($326K) and 0 sales, across 1 company.
- Transactions
- 6
- Purchases (P)
- 6
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- STEPHENSON BRIAN C
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | Officer · Chief Financial Officer | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Faeth Therapeutics, Inc. | P | 600 | $24.22 | 46,688 | Form 4 |
| 2026-07-01 | Faeth Therapeutics, Inc. | P | 4,400 | $23.4 | 46,088 | Form 4 |
| 2026-06-30 | Faeth Therapeutics, Inc. | P | 1,638 | $23.88 | 37,433 | Form 4 |
| 2026-06-30 | Faeth Therapeutics, Inc. | P | 1,910 | $22.95 | 35,795 | Form 4 |
| 2026-06-30 | Faeth Therapeutics, Inc. | P | 4,255 | $24.98 | 41,688 | Form 4 |
| 2026-06-29 | Faeth Therapeutics, Inc. | P | 831 | $23.34 | 33,885 | Form 4 |
Questions
What stock did Stephenson Brian C buy or sell?
Stephenson Brian C reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 6 open-market purchases ($326K) and 0 sales, across 1 company.
Is Stephenson Brian C the same person as other filers with this name?
This page covers SEC CIK 1780030 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/stephenson-brian-c-1780030.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.